Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alpha-1 Foundation
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and female adults at least 18 years of age able to understand and consent to the procedures of this protocol.
All races and ethnicities will be considered for this study.
Post-bronchodilator values for pulmonary function tests on the day of enrollment with an FEV1 \< 80% of predicted and FEV1/FVC \< 70% (at least GOLD stage II).
Subjects who have been tested for Alpha-1 in the past but do not know their genotype or phenotype may be included in this study.
You may not be if
Subjects in whom post-bronchodilator spirometry is not performed.
Subjects whose ordering physician has specifically requested that his patients not be considered for enrollment.
Patients who have been tested for Alpha-1 in the past and know their genotype or phenotype.
Clareo Health | Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD)
